Because RBR is essential and expressed in nearly all cells, to accurately assay its role as a potential partner of FAMA in the stomatal lineage, we generated a Myc-tagged version of RBR expressed under the FAMA promoter (FAMAp RBR-MYC).
After 7 days of incubation at 25°C as stationary culture, the contents were filtered through Whatman filter paper no. 1 and the filtrate obtained was used for assaying its antimicrobial potential.
The CP approach is another tool enhancing the effectiveness and versatility of SMAP 2 assays, expanding its potential applications, and reinforcing its position as a highly effective technology for molecular diagnostics.
The robust performance of the one-step assay suggests its potential in envisaging a rapid point-of-care assay.
This assay demonstrates its potential in clinical diagnostic and therapeutic monitoring.
The optimal decoy receptor fusion protein with the highest binding affinity for FGF-2 was identified by an FGF-2-binding assay and its potential antitumour effects were investigated.
Next, we assayed PfI2 for its potential capacity to regulate PfPP1 activity.
Moreover, P1 shows low cytotoxicity by CCK-8 assay, which makes its potential application as fluorescent agent for cellular imaging.
A tagless recombinantly-expressed peptide corresponding to FnBR9,10 (two high-affinity repeats) was used in an assay to examine its potential to block adhesion and invasion (Fig. 8).
To explore the full versatility of the ChIn assay, we investigated its potential for detecting genetic mutations within critical pathways of an innate immune response.
